UbiVac
Home Collaboration Contact
New Index
Overview Executive Leadership Board of Directors Advisory Board
Technologies Pipeline
Presentations Publications Press Releases In the News
Home About Overview Executive Leadership Board of Directors Advisory Board Research & Pipeline Technologies Pipeline Collaboration Newsroom Presentations Publications Press Releases In the News Contact
UbiVac
New Index

Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses Against Short-lived Proteins Through a p62-Dependent Mechanism

Christopher G. Twitty, Shawn M. Jensen, Hong-Ming Hu, and Bernard A. Fox

Clinical Cancer Research, October 15, 2011

Bernie FoxJune 4, 2018
Facebook0 Twitter 0 Likes
Previous

Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy

Bernie FoxJune 4, 2018
Next

Cross-presentation of Tumor Associated Antigens Through Tumor-derived Autophagosomes

Bernie FoxJune 4, 2018

© 2020 UbiVac | All rights reserved.